LOS ANGELES & SINGAPORE–(BUSINESS WIRE)– #APAC–MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional associatio…
Author: Business Wire
JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System
LIBERTYVILLE, Ill.–(BUSINESS WIRE)– #SaMD–JuneBrain is excited to announce our selection to receive a grant award from the Medical Device Innovation Consortium’s Advanced Manufacturing Clearing House program! The $300,000 award has been afforded to …
Endoscopy Market Insights & Forecast 2024-2028, Featuring Profiles of Leading Players Ethicon Endo-Surgery Inc., Medtronic, Fujifilm, Boston Scientific, Olympus and Ambu – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Endoscopy Market (by Product, Application, End-User & Region): Insights & Forecast (2024-2028)” report has been added to ResearchAndMarkets.com’s offering. The global endoscopy market is predicted to reach U…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announce…
Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Ora Partners with the Institute of Eye Surgery to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments
LONDON & BOSTON–(BUSINESS WIRE)– #ophthalmology–Ora, the leading global ophthalmic contract research organisation (CRO), announced today its partnership with Institute of Eye Surgery, Ireland’s largest private ophthalmology service provider known fo…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchas…
LENSAR to Participate in Two Upcoming Investor Conferences
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR®, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that management will participate in two up…
From Beauty Icon to Medical Pioneer: Victoria Jackson's New Book Walks You Through Her Journey from Worrier to Warrior
NEW YORK–(BUSINESS WIRE)–Cosmetics visionary, medical trailblazer, and sexual assault survivor Victoria Jackson’s new book We All Worry, Now What? published by award-winning book producer Melcher Media goes on shelves everywhere books are sold today….
Aurion Biotech to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) and Ophthalmology European Futures Forum
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it will present clinical data on its allogeneic cell therapy…
Samsara Vision Promotes Jason Herod to Chief Commercial Officer
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision announces that Jason Herod is promoted to Chief Commercial Officer, effective August 15, 2024.
Warby Parker Announces Participation in the Goldman Sachs 31st Annual Global Retailing Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 31st Annual Global Retailing Conference …
Stoke Therapeutics to Present at Upcoming Investor Conferences in September
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that management will present at the follow…
Harrow to Present at Three Investor Conferences in September in New York
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences in September in New York: H.C. Wai…
Banuba Introduces Pupillary Distance Measurement for Opticians and Eyewear Stores
DUBAI, United Arab Emirates–(BUSINESS WIRE)– #AR–Banuba adds an innovative pupillary distance (PD) measurement to its Face AR SDK, enhancing accuracy for medical uses and virtual eyewear try-on.
National Vision Holdings, Inc. Announces Participation in the Goldman Sachs 31st Annual Global Retailing Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced that the Company is scheduled to present at the Goldman Sachs 31st Annual Global Retailing Conference on Wednesday, September 4, 2024, at 1:10 p.m. Eastern Time….
Avanzanite Bioscience comunica di aver ricevuto l'autorizzazione da parte della Commissione europea del medicinale orfano AKANTIOR®
AMSTERDAM–(BUSINESS WIRE)–Avanzanite Bioscience B.V., un’azienda farmaceutica specializzata in fase di sviluppo commerciale, focalizzata sull’introduzione sul mercato di nuovi farmaci per le malattie rare, ha annunciato oggi che la Commissione Europe…
Avanzanite Bioscience rapporteert de goedkeuring van de Europese Commissie voor het weesgeneesmiddel AKANTIOR®
AMSTERDAM–(BUSINESS WIRE)–Avanzanite Bioscience B.V., een gespecialiseerd farmaceutisch bedrijf van commerciële fase dat zich toespitst op de marktintroductie van nieuwe geneesmiddelen ter behandeling van zeldzame ziektes, maakte vandaag bekend dat d…
Avanzanite Bioscience informa sobre la autorización por parte de la Comisión Europea del medicamento huérfano AKANTIOR®
AMSTERDAM–(BUSINESS WIRE)–Avanzanite Bioscience B.V., empresa farmacéutica especializada en la fase comercial, centrada en lanzar al mercado medicamentos novedosos para enfermedades raras, ha anunciado hoy que la Comisión Europea (CE) ha concedido la…
Avanzanite Bioscience berichtet über die Zulassung durch die Europäische Kommission des Arzneimittels für seltene Leiden AKANTIOR®
AMSTERDAM–(BUSINESS WIRE)–Avanzanite Bioscience B.V., ein Spezialpharmaunternehmen, das sich darauf konzentriert, neuartige Medikamente für seltene Krankheiten auf den Markt zu bringen, gab heute bekannt, dass die Europäische Kommission (EK) die Mark…